首页> 外文期刊>Journal of educational technology systems >VIRTUOUS OR VICIOUS?: AGENCY AND REPRESENTATION IN BIOTECHNOLOGY'S VIRTUOUS CYCLE
【24h】

VIRTUOUS OR VICIOUS?: AGENCY AND REPRESENTATION IN BIOTECHNOLOGY'S VIRTUOUS CYCLE

机译:是虚拟的还是虚拟的?:生物技术虚拟周期中的代理和代表

获取原文
获取原文并翻译 | 示例
           

摘要

This article provides a fresh examination of claims that biotechnology and other high profile areas of scientific research and development create a "virtuous cycle" that delivers benefits to society and ecology through an array of consumer products. Specifically, the article investigates who and what has agency in this virtuous cycle and who and what does not. I argue that official discourses on and definitions of biotechnology create strict demarcations not only on who can act in relation to biotechnology research development options, but also on where and at which stages of the virtuous cycle these agents can act. For example, scientists are presented as passive rather than active agents whose influence is limited to the laboratory context despite rhetorical use of their identity and credibility across all contexts of product development and consumption explored. Agency is highly significant in biotechnology and other areas of scientific advance because it determines who or what has moral decision making power regarding the place of new technologies in society. The article concludes with a discussion of the social and ethical impacts of these demarcations of agency in biotechnology's virtuous cycle.
机译:本文重新审视了生物技术和科学研究的其他高知名度领域所创造的“良性循环”,这种“良性循环”通过一系列消费产品为社会和生态带来了好处。具体而言,本文调查了在这个良性循环中谁和什么拥有代理权,谁没有什么具有代理权。我认为,关于生物技术的官方论述和定义不仅对谁可以在生物技术研究发展选择方面采取行动,而且还对这些行为者可以在良性循环的哪个阶段和哪个阶段采取行动进行了严格的划分。例如,科学家被认为是被动的而不是主动的试剂,尽管在研究的产品开发和消费的所有环境中都夸夸其谈地使用了他们的身份和信誉,但他们的影响仅限于实验室。代理机构在生物技术和其他科学进步领域中具有举足轻重的地位,因为它决定了谁或什么人对社会上新技术的地位具有道德决策权。本文最后讨论了在生物技术的良性循环中这些机构划分的社会和伦理影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号